Sukhtian Faisal Ghiath 4
4 · Outlook Therapeutics, Inc. · Filed Feb 6, 2025
Insider Transaction Report
Form 4
Sukhtian Faisal Ghiath
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-04+12,323→ 12,323 totalExercise: $1.82Exp: 2035-02-04→ Common Stock (12,323 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest in three (3) equal installments on each of March 31, 2025, June 30, 2025 and September 30, 2025, subject to the Optionholder's Continuous Service to the Issuer through such vesting date.